NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.985

+5.0%

Nov 5 3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Straynut	3/10/2017 1:57:42 PM
	2 Recommendations Recommended By donpat Kirk © Read Replies (6) of 12871

A Single-Mindedness: A Single Objective..... A response from Dr Seymour to an email from "A large shareholder". If you want to get excited about the prospects for the future, don't limit yourself to thinking only about shingles. This system we have is really a "herpes franchise". Make a list of all the diseases that are caused by the various strains of the herpes virus and then you'll understand the universe of applications. That's why the first one out of the box must work so well. Got it? Gene Eugene Seymour, MD MPH Chief Executive Officer NanoViricides, Inc eugene@nanoviricides.com 310-486-5677 Sent from my iPad On Mar 10, 2017, at 3:47 AM To All: IMO this company is on the cusp of finally achieving the perfection that Anil has long sought: creating a shingles drug in topical form that will cure the terrible pain incident to this disease, in days if not HOURS. 2017 is finally the year, and I don't want to clutter your minds with anything but news and commentary about anything but my single objective: proving to you once and for all that this company has achieved a CURE for all viruses. =A large shareholder

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next